Associated Papers
Long-term safety and efficacy of velmanase alfa treatment in children under 6 years of age with alpha-mannosidosis: A phase 2, open label, multicenter study.
Guffon N et al.
Journal of Inherited Metabolic Disease, 2023
Select a paper to view details